microdosing tirzepatide twice a week Tirzepatide: What You Need to Know Is Microdosing GLP-1s Safe? What

& Cravatt, B

Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews

those with diabetes or obesity but no medication (300,000 patients in the study) Those on GLP-1 meds were 66% more likely to have gastroparesis 0.53% of patients had paralysis that is the equivalent of 1 in every 200 people on semaglutide or tirzepatide They were more likely to have nausea, vomition, or reflux and be prescribed a proton pump inhibitor They were more likely to have drug-induced pancreatitis and need gallbladder removal

Those seeking FDA-approved options can explore branded medications through traditional healthcare channels

For migraines, essential tremor, or situational anxiety, your propranolol dose should stay stable